© 2020 MJH Life Sciences and Rheumatology Network. All rights reserved.
© 2020 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
February 11, 2016
In this op-ed, specialty medicine experts address the value of biosimilars in specialty care. Value, they write, is a "three-legged stool supported by efficacy, toxicity and cost."